Search
Apellis Pharmaceuticals Inc
APLSAdd to Watchlist
41.030USD
0.0000.00%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
5.25BMarket Cap
38.75P/E TTM
Risk Assessment
Currency: USD Updated: 2026-05-13Apellis Pharmaceuticals Inc’s latest ESG disclosure leads the Pharmaceuticals industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
Beta vs S&P 500 index
-0.25
VaR
+5.17%
240-Day Maximum Drawdown
+43.53%
240-Day Volatility
+103.26%
Return
Best Daily Return
60 days
+135.40%
120 days
+135.40%
5 years
+135.40%
Worst Daily Return
60 days
-5.11%
120 days
-15.02%
5 years
-37.92%
Sharpe Ratio
60 days
+1.70
120 days
+1.31
5 years
+0.28
Risk Assessment
Maximum Drawdown
240 days
+43.53%
3 years
+82.04%
5 years
+82.47%
Return-to-Drawdown Ratio
240 days
+3.12
3 years
-0.22
5 years
-0.09
Skewness
240 days
+11.85
3 years
+11.33
5 years
+10.17
Volatility
Realised Volatility
240 days
+103.26%
5 years
+81.44%
Standardised True Range
240 days
+2.57%
5 years
+5.73%
Downside Risk-Adjusted Return
120 days
+694.78%
240 days
+694.78%
Maximum Daily Upside Volatility
60 days
+279.50%
Maximum Daily Downside Volatility
60 days
+282.40%
Liquidity
Average Turnover Rate
60 days
+5.09%
120 days
+3.67%
5 years
--
Turnover Deviation
20 days
+145.10%
60 days
+115.47%
120 days
+55.58%
